Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders
Crossref DOI link: https://doi.org/10.1007/s40259-014-0104-3
Published Online: 2014-06-13
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sanford, Mark
Text and Data Mining valid from 2014-06-13